IP Library Granted Patent US 7,384,749
Granted Patent B2
US 7,384,749 · App. 11/343,462 · Granted Jun 10, 2008

Electrodes linked via conductive oligomers to nucleic acids

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,384,749
App. No.
11/343,462
Granted
Jun 10, 2008
Kind
B2
Abstract

The invention relates to nucleic acids covalently coupled to electrodes via conductive oligomers. More particularly, the invention is directed to the site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials, and to methods of making and using them.

Claims (17)

1. A method of detecting a target nucleic acid sequence in a nucleic acid sample comprising

a) providing a solid support comprising an array of electrodes each comprising:

i) a covalently attached anchor sequence; and

ii) a self-assembled monolayer;

b) contacting said array with at least one target sequence and a second nucleic acid sequence comprising a first region substantially complementary to said anchor sequence and a second region substantially complementary to a region of said target sequence, to form a hybridization complex; wherein said hybridization complex further comprises an electron transfer moiety (ETM); and

c) detecting the presence of said ETM as an indication of the presence of said target nucleic acid sequence.

2. A method according to claim 1 wherein said ETM is covalently attached to said target sequence.

3. A method according to claim 1 wherein said hybridization complex further comprises a label probe comprising said ETM.

4. A method according to claim 1 wherein said hybridization complex comprises a plurality of ETMs.

5. A method according to claim 1 wherein said ETM is a metallocene.

6. A method according to claim 5 wherein said metallocene is ferrocene.

7. A method according to claim 6 wherein said ferrocene is a ferrocene derivative.

8. A method according to claim 1 wherein said self-assembled monolayer comprises conductive oligomers.

9. A method according to claim 1 wherein said self-assembled monolayer comprises insulators.

10. A method according to claim 1 where said covalent attachment is via a spacer.

11. A method according to claim 10 wherein said spacer is a conductive oligomer.

12. A method according to claim 10 wherein said spacer is an insulator.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
Continuity (5)
Continuation 0955757700 · Apr 21, 2000
Continuation 0891108500 · Aug 14, 1997
Continuation 0887397800 · Jun 12, 1997
Continuation In Part 0874379800 · Nov 5, 1996
Related Publication 20060211016A1 · Sep 21, 2006